Status:
TERMINATED
Contribution of PRF in CDH in Children With Prothetic Patch Closure
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Congenital Diaphragmatic Hernias
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
Improved management of giant congenital diaphragmatic hernias (CDH) in neonates : decreased risk of morbidity and mortality due to prosthesis release. CDH is a rare disease with a still very dark prog...
Eligibility Criteria
Inclusion
- Adult Healthy Volunteers :
- \- Over 18 years of age
- Neonates:
- Aged between 1h of life and 28 days of life
- Born beyond 33 Week of Amenorrhea + 1day and 2kg of birth weight
- Hospitalized in the medical-surgical centre of Pediatrics of the hospital of Strasbourg
- For whom a blood sample was prescribed as part of their routine care
Exclusion
- Adult Healthy Volunteers :
- Systemic inflammatory disease
- Transient inflammatory state
- Any drug that modifies the coagulation cascade during the 48h preceding the sampling
- Neonates:
- Risk of anemia \< 7g/DL
- Current anticoagulant treatment
Key Trial Info
Start Date :
September 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03861182
Start Date
September 12 2019
End Date
December 10 2019
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67 091